Abstract: A decking assembly having a first deck section with a male leg and a second deck positioned adjacent to and in overlapping relationship to the first deck section. The second deck section has a female leg overlying the male leg of the first deck section. The male leg and the female leg have a triangular tab formed therethrough such that the triangular tab extends outwardly on one side of the female leg so as to secure the edges of the sections together in secure relationship. A plurality of triangular tabs are formed in spaced relationship to each other.

Abstract: A modified extracellular domain of a cytokine receptor is capable of being crystallized without being complexed to a ligand molecule. The receptor preferably is a homo- or heterodemeric receptor having at least one molecule segment which contributes to a disorder structure deleted. A preferred receptor is human growth hormone receptor (hGHR).

Abstract: A compound of formula (I) is provided which is able to interact with &bgr;-catenin/TCF-4 binding site, having a structure essentially equivalent to a pharmacophore (IA), as herein described.

Abstract: A modified extracellular domain of a cytokine receptor protein is capable of being crystallized without being complexed to a ligand molecule. The receptor preferably is a homo- or heterodimeric receptor having at least one molecule segment which contributes to a disordered structure deleted. A preferred receptor is human growth hormone receptor (hGHR).

Abstract: A decking assembly having a first deck section with a male leg and a second deck positioned adjacent to and in overlapping relationship to the first deck section. The second deck section has a female leg overlying the male leg of the first deck section. The male leg and the female leg have a triangular tab formed therethrough such that the triangular tab extends outwardly on one side of the female leg so as to secure the edges of the sections together in secure relationship. A plurality of triangular tabs are formed in spaced relationship to each other.

Abstract: Disclosed as a modified extracellular domain of a cytokine receptor protein, capable of being crystallized without being complexed to a ligand molecule. The receptor preferably is a homo- or heterodimeric cytokine receptor, having at least one molecule segment which contributes to a disordered structure deleted. The most preferred receptor is human growth hormone receptor (hGHR). Also disclosed are crystals of unliganded modified receptor suitable for binding studies with ligand candidates a method of obtaining the crystals, as well as a method of designing drugs with cytokine receptor activity by employing such crystals according in binding studies with selected ligand candidates.

Abstract: A protective respiratory device (1) in the form of a half-mask (2) is designed to cover the nose and the mouth of the wearer and is combined with a bag-shaped hood (3) designed to enclose the head of the wearer and provided with a visor (12) in front. Round the bag opening, the hood (3) is provided with an elastic sleeve designed to surround the neck of the wearer in a tight-fitting fashion. A first elastic band (9) arranged in the hood extends between the two sides of the half-mask and is intended to be applied round the back of the head or the nape of the neck of the wearer. A second elastic band (13) arranged in the hood and extending rearwards from a hood portion corresponding to the forehead of the wearer is connected to the first band (9) at the back. The second band (13) is adapted to be placed over the crown of the head of the wearer and has such a width that it will then largely surround the head of the wearer also laterally.